ViiV Healthcare Launches Campaign to Boost HIV Prevention Adherence
Event summary
- ViiV Healthcare launched the “Do It For Future You” campaign on August 4, 2026 to promote long-acting injectable HIV prevention and treatment options.
- The campaign aims to address critical gaps in care, with only 25% of eligible individuals currently taking PrEP and 31% of U.S. HIV patients not achieving viral suppression.
- Long-acting injectables have been shown to improve adherence and persistence, contributing to better health outcomes and reduced transmission.
- The campaign includes a website (ForFutureU.com) with resources for discussing treatment options with healthcare providers.
The big picture
ViiV Healthcare's campaign reflects the broader industry shift towards long-acting injectable solutions for chronic conditions, aiming to improve patient adherence and outcomes. The initiative is strategically positioned to address persistent gaps in HIV care, particularly among populations facing barriers to daily medication routines or stigma-related access issues.
What we're watching
- Adoption Pace
- How quickly long-acting injectable options will be adopted by individuals and healthcare providers.
- Market Impact
- Whether the campaign can significantly increase PrEP uptake and viral suppression rates among at-risk populations.
- Competitive Dynamics
- The potential for other pharmaceutical companies to introduce competing long-acting HIV prevention treatments.
Related topics